17 April 2018Biotechnology
Shire to sell oncology business for $2.4bn
Biotech company Shire has revealed plans to sell its oncology business for $2.4 billion to France-based Servier.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Asia-Pacific
3 April 2018 Japan-based Takeda has revealed that it is considering plans to acquire biopharmaceutical company Shire.
Asia-Pacific
23 April 2018 Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.
Big Pharma
8 May 2018 Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Editor's picks
Editor's picks
Asia-Pacific
3 April 2018 Japan-based Takeda has revealed that it is considering plans to acquire biopharmaceutical company Shire.
Asia-Pacific
23 April 2018 Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.
Big Pharma
8 May 2018 Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.
Asia-Pacific
3 April 2018 Japan-based Takeda has revealed that it is considering plans to acquire biopharmaceutical company Shire.
Asia-Pacific
23 April 2018 Japan-based Takeda has upped its offer to buy Ireland-headquartered Shire for the fourth time, raising its bid to approximately £44 billion.
Big Pharma
8 May 2018 Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.